A recurrent mutation in PARK2 is associated with familial lung cancer

Donghai Xiong, Yian Wang, Elena Kupert, Claire Simpson, Susan M. Pinney, Colette R. Gaba, Diptasri Mandal, Ann G. Schwartz, Ping Yang, Mariza De Andrade, Claudio Pikielny, Jinyoung Byun, Yafang Li, Dwight Stambolian, Margaret R. Spitz, Yanhong Liu, Christopher I. Amos, Joan E. Bailey-Wilson, Marshall Anderson, Ming You

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

PARK2, a gene associated with Parkinson disease, is a tumor suppressor in human malignancies. Here, we show that c.823C>T (p.Arg275Trp), a germline mutation in PARK2, is present in a family with eight cases of lung cancer. The resulting amino acid change, p.Arg275Trp, is located in the highly conserved RING finger 1 domain of PARK2, which encodes an E3 ubiquitin ligase. Upon further analysis, the c.823C>T mutation was detected in three additional families affected by lung cancer. The effect size for PARK2 c.823C>T (odds ratio = 5.24) in white individuals was larger than those reported for variants from lung cancer genome-wide association studies. These data implicate this PARK2 germline mutation as a genetic susceptibility factor for lung cancer. Our results provide a rationale for further investigations of this specific mutation and gene for evaluation of the possibility of developing targeted therapies against lung cancer in individuals with PARK2 variants by compensating for the loss-of-function effect caused by the associated variation.

Original languageEnglish (US)
Pages (from-to)301-308
Number of pages8
JournalAmerican Journal of Human Genetics
Volume96
Issue number2
DOIs
StatePublished - Feb 5 2015

Fingerprint

Lung Neoplasms
Mutation
Germ-Line Mutation
RING Finger Domains
Ubiquitin-Protein Ligases
Genome-Wide Association Study
Genetic Predisposition to Disease
Genes
Parkinson Disease
Neoplasms
Odds Ratio
Amino Acids
Therapeutics

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cite this

A recurrent mutation in PARK2 is associated with familial lung cancer. / Xiong, Donghai; Wang, Yian; Kupert, Elena; Simpson, Claire; Pinney, Susan M.; Gaba, Colette R.; Mandal, Diptasri; Schwartz, Ann G.; Yang, Ping; De Andrade, Mariza; Pikielny, Claudio; Byun, Jinyoung; Li, Yafang; Stambolian, Dwight; Spitz, Margaret R.; Liu, Yanhong; Amos, Christopher I.; Bailey-Wilson, Joan E.; Anderson, Marshall; You, Ming.

In: American Journal of Human Genetics, Vol. 96, No. 2, 05.02.2015, p. 301-308.

Research output: Contribution to journalArticle

Xiong, D, Wang, Y, Kupert, E, Simpson, C, Pinney, SM, Gaba, CR, Mandal, D, Schwartz, AG, Yang, P, De Andrade, M, Pikielny, C, Byun, J, Li, Y, Stambolian, D, Spitz, MR, Liu, Y, Amos, CI, Bailey-Wilson, JE, Anderson, M & You, M 2015, 'A recurrent mutation in PARK2 is associated with familial lung cancer', American Journal of Human Genetics, vol. 96, no. 2, pp. 301-308. https://doi.org/10.1016/j.ajhg.2014.12.016
Xiong, Donghai ; Wang, Yian ; Kupert, Elena ; Simpson, Claire ; Pinney, Susan M. ; Gaba, Colette R. ; Mandal, Diptasri ; Schwartz, Ann G. ; Yang, Ping ; De Andrade, Mariza ; Pikielny, Claudio ; Byun, Jinyoung ; Li, Yafang ; Stambolian, Dwight ; Spitz, Margaret R. ; Liu, Yanhong ; Amos, Christopher I. ; Bailey-Wilson, Joan E. ; Anderson, Marshall ; You, Ming. / A recurrent mutation in PARK2 is associated with familial lung cancer. In: American Journal of Human Genetics. 2015 ; Vol. 96, No. 2. pp. 301-308.
@article{17c5b33a20364111b13a11871041100f,
title = "A recurrent mutation in PARK2 is associated with familial lung cancer",
abstract = "PARK2, a gene associated with Parkinson disease, is a tumor suppressor in human malignancies. Here, we show that c.823C>T (p.Arg275Trp), a germline mutation in PARK2, is present in a family with eight cases of lung cancer. The resulting amino acid change, p.Arg275Trp, is located in the highly conserved RING finger 1 domain of PARK2, which encodes an E3 ubiquitin ligase. Upon further analysis, the c.823C>T mutation was detected in three additional families affected by lung cancer. The effect size for PARK2 c.823C>T (odds ratio = 5.24) in white individuals was larger than those reported for variants from lung cancer genome-wide association studies. These data implicate this PARK2 germline mutation as a genetic susceptibility factor for lung cancer. Our results provide a rationale for further investigations of this specific mutation and gene for evaluation of the possibility of developing targeted therapies against lung cancer in individuals with PARK2 variants by compensating for the loss-of-function effect caused by the associated variation.",
author = "Donghai Xiong and Yian Wang and Elena Kupert and Claire Simpson and Pinney, {Susan M.} and Gaba, {Colette R.} and Diptasri Mandal and Schwartz, {Ann G.} and Ping Yang and {De Andrade}, Mariza and Claudio Pikielny and Jinyoung Byun and Yafang Li and Dwight Stambolian and Spitz, {Margaret R.} and Yanhong Liu and Amos, {Christopher I.} and Bailey-Wilson, {Joan E.} and Marshall Anderson and Ming You",
year = "2015",
month = "2",
day = "5",
doi = "10.1016/j.ajhg.2014.12.016",
language = "English (US)",
volume = "96",
pages = "301--308",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - A recurrent mutation in PARK2 is associated with familial lung cancer

AU - Xiong, Donghai

AU - Wang, Yian

AU - Kupert, Elena

AU - Simpson, Claire

AU - Pinney, Susan M.

AU - Gaba, Colette R.

AU - Mandal, Diptasri

AU - Schwartz, Ann G.

AU - Yang, Ping

AU - De Andrade, Mariza

AU - Pikielny, Claudio

AU - Byun, Jinyoung

AU - Li, Yafang

AU - Stambolian, Dwight

AU - Spitz, Margaret R.

AU - Liu, Yanhong

AU - Amos, Christopher I.

AU - Bailey-Wilson, Joan E.

AU - Anderson, Marshall

AU - You, Ming

PY - 2015/2/5

Y1 - 2015/2/5

N2 - PARK2, a gene associated with Parkinson disease, is a tumor suppressor in human malignancies. Here, we show that c.823C>T (p.Arg275Trp), a germline mutation in PARK2, is present in a family with eight cases of lung cancer. The resulting amino acid change, p.Arg275Trp, is located in the highly conserved RING finger 1 domain of PARK2, which encodes an E3 ubiquitin ligase. Upon further analysis, the c.823C>T mutation was detected in three additional families affected by lung cancer. The effect size for PARK2 c.823C>T (odds ratio = 5.24) in white individuals was larger than those reported for variants from lung cancer genome-wide association studies. These data implicate this PARK2 germline mutation as a genetic susceptibility factor for lung cancer. Our results provide a rationale for further investigations of this specific mutation and gene for evaluation of the possibility of developing targeted therapies against lung cancer in individuals with PARK2 variants by compensating for the loss-of-function effect caused by the associated variation.

AB - PARK2, a gene associated with Parkinson disease, is a tumor suppressor in human malignancies. Here, we show that c.823C>T (p.Arg275Trp), a germline mutation in PARK2, is present in a family with eight cases of lung cancer. The resulting amino acid change, p.Arg275Trp, is located in the highly conserved RING finger 1 domain of PARK2, which encodes an E3 ubiquitin ligase. Upon further analysis, the c.823C>T mutation was detected in three additional families affected by lung cancer. The effect size for PARK2 c.823C>T (odds ratio = 5.24) in white individuals was larger than those reported for variants from lung cancer genome-wide association studies. These data implicate this PARK2 germline mutation as a genetic susceptibility factor for lung cancer. Our results provide a rationale for further investigations of this specific mutation and gene for evaluation of the possibility of developing targeted therapies against lung cancer in individuals with PARK2 variants by compensating for the loss-of-function effect caused by the associated variation.

UR - http://www.scopus.com/inward/record.url?scp=84925106543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925106543&partnerID=8YFLogxK

U2 - 10.1016/j.ajhg.2014.12.016

DO - 10.1016/j.ajhg.2014.12.016

M3 - Article

VL - 96

SP - 301

EP - 308

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 2

ER -